REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 207 filers reported holding REVOLUTION MEDICINES INC in Q1 2024. The put-call ratio across all filers is 0.35 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,563,461 | -31.5% | 40,285 | -43.1% | 0.01% | -25.0% |
| Q1 2024 | $2,282,948 | +289.9% | 70,833 | +162.0% | 0.01% | +166.7% |
| Q1 2023 | $585,535 | -74.4% | 27,033 | -71.9% | 0.00% | -76.9% |
| Q4 2022 | $2,289,340 | -53.7% | 96,110 | -61.6% | 0.01% | -51.9% |
| Q3 2022 | $4,941,000 | +126.1% | 250,571 | +123.5% | 0.03% | +145.5% |
| Q2 2022 | $2,185,000 | -7.7% | 112,134 | +20.8% | 0.01% | -15.4% |
| Q1 2022 | $2,368,000 | +61.2% | 92,825 | +73.9% | 0.01% | +44.4% |
| Q3 2021 | $1,469,000 | +237.7% | 53,384 | +289.6% | 0.01% | +200.0% |
| Q2 2021 | $435,000 | -81.1% | 13,701 | -72.7% | 0.00% | -82.4% |
| Q1 2021 | $2,300,000 | -33.5% | 50,141 | -42.6% | 0.02% | -41.4% |
| Q4 2020 | $3,458,000 | – | 87,335 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 1,909,317 | $75,590,000 | 52.65% |
| TRV GP III, LLC | 7,024,031 | $278,081,000 | 23.88% |
| Ponoi II Management, LLC | 685,011 | $27,120,000 | 19.76% |
| TRV GP IV, LLC | 1,419,900 | $56,214,000 | 18.03% |
| Ponoi Management, LLC | 685,011 | $27,120,000 | 15.52% |
| Column Group LLC | 3,580,252 | $141,742,000 | 12.86% |
| BVF INC/IL | 2,768,049 | $109,587,000 | 4.31% |
| Boxer Capital, LLC | 3,309,264 | $131,014,000 | 4.21% |
| Cormorant Asset Management, LP | 2,495,066 | $98,780,000 | 2.35% |
| Casdin Capital, LLC | 1,634,535 | $64,711,000 | 1.92% |